SBRT 2016

Combining local and systemic therapies

Progression free survival after resection +/- FOLFOX4

Clinical results

HR: 0.79 (CI 0.622–1.02; p=0.058) in all randomly assigned patients

EORTC 40983 Nordlinger et al: Lancet (2008) 371:1007